The 66th American Academy of Neurology Annual Meeting
Today marks the third day of the 66th Annual Meeting of the American Academy of Neurology in Philadelphia, Pennsylvania. Each year the meeting brings…
MS Society-funded researchers lead the pack in myelin repair research
MS researchers recognize that myelin repair following a relapse or ‘attack’ is the key to preventing disease progression and irreversible disability. With many…
Highlights from the 5th Annual Neuroinflammation Symposium
Last week I attended the 5th Annual Neuroinflammation Symposium – an interactive and interdisciplinary series of presentations focused on research in neuroinflammation. Neuroinflammation…
A critical partnership to speed the delivery of treatments, and ultimately find a cure, for MS
I’m here in Vancouver, British Columbia with MS Society colleagues, government officials, donors and people living with MS to take part in a…
A special announcement from the MS Society
February has turned out to be a very busy month for the MS Society. Today we announced the launch of a collaborative study…
Happy New Year from the MS Society Research team!
Welcome to 2014! I hope you all had a joyful, warm, and well-rested holiday. As the MS Society office took a short break,…
Timing is everything!
Dr. Charles ffrench-Constant is a professor at the University of Edinburgh, director of the MRC Centre for Regenerative Medicine, and a pioneer in…
What is MS?
Canada has one of the highest rates of multiple sclerosis (MS) in the world, with an estimated 77,000 Canadians living with the disease. While it is most often diagnosed in young adults aged 20 to 49, younger children and older adults are also diagnosed with the disease.